Leading the Way
For two decades, Cambridge Biomedical has been there to deliver the strategies and solutions you need. Now, meet the leadership team charting a course into the future of bioanalytical services.
Owner, CEO, and Chairwoman
From the founding of Cambridge Biomedical in 1997, Barbara recognized the need in the industry for a company that could serve as more than a provider of testing services to life sciences companies. She has consistently put into place elements that support her vision of becoming a valuable resource to our clients by providing them with unrivaled customer service built on a foundation of solid science and backed by a strong organization with consistent financial performance.
Cambridge Biomedical today benefits from her strategic vision and management style as it remains a profitable independent company, able to invest in key areas that allow it to prosper and continue to support its customers. Barbara received degrees from The College of New Rochelle and Sarah Lawrence College.
President and COO
Brad has been a board member since 2010 and was appointed President and COO in May 2015, responsible for all operational areas in Cambridge Biomedical
“Cambridge Biomedical’s strength in bioanalytical assays and diagnostic testing is well known in the industry and I am greatly energized to help lead this company with its team of highly experienced staff through its next phase of growth tied to operational excellence.”
Prior to this appointment, Brad was responsible for the operations of several different companies in market research, architecture design and products, and specialty materials. He received a B.S. in Mechanical Engineering from Virginia Tech and an MBA from Northeastern University
Vice President of Technical Affairs
Linda Robbie, Ph.D. joined Cambridge Biomedical Inc. as vice president of scientific affairs in June 2017. In this role, Linda is a key member of the leadership team. She directs all initiatives related to science and technology and the introduction of new products and services, serving as the scientific expert and interfacing with both clients and internal teams.
Before joining Cambridge, Linda served as global senior director of the biomarkers and translational science laboratory at Q2 Solutions Laboratories, a Quintiles-Quest Joint Venture, and as senior director of the global assay development laboratory at Quintiles Laboratories. She was a research fellow at the University of Aberdeen and, after receiving the British Society for Hematology Research Fellowship, served as a research fellow at Harvard Medical School in Boston.